ArticleParasitology research2025
Albendazole treatment efficacy and predictors of success in combating soil-transmitted helminth infections in school children of Central Tigray, Northern Ethiopia.
Article in Parasitology research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The present study evaluated the efficacy of albendazole in treating soil-transmitted helminth infections among school children aged 6 to 15 years in three districts of Central Tigray, Ethiopia. A total of 1020 elementary school children were screened from three schools using Kato-Katz and microscopic detection techniques. Of these, 35.2% (359/1020) of children were infected with one or more soil-transmitted helminths and were treated with 400 mg albendazole. The efficacy of the drug was assessed by measuring the percentage reduction in helminth egg counts using Kato-Katz. Albendazole was most effective against hookworm, with overall 94.1% egg reduction rates (ERRs), 3 weeks post-treatment followed by A. lumbricoides and T. trichiura, with overall ERRs of 83.9% and 31%, respectively. Analysis of factors affecting albendazole treatment success revealed that the age of respondents, source of drinking water, and infection intensity at baseline were significant predictors of treatment success. School children 6-8 years old showed higher ERRs, while those using stream water for drinking purposes and with multiple parasite infections at baseline had lower probability of ERRs. These findings demonstrate the varying efficacy of albendazole across different STH infections and geographical locations, calling a more refined research to enhance treatment approaches for A. lumbricoides and T. trichiura. This study underscores the need for context-specific therapeutic intervention to enhance treatment success in endemic areas.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.